Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
| Fund Name: | RA Capital Management |
| Manager | Peter Kolchinsky |
| Portfolio Value | $1,717,985,000 |
| Change This QTR | +0.92% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1. | WVE | 7,512,049 | $315,807 | 18.38% | ||
| 2. | ASND | 4,240,536 | $265,670 | 15.46% | ||
| 3. | Synthorx Inc | 9,724,598 | $169,014 | 9.83% | ||
| 4. | ZGNX | 2,382,168 | $86,854 | +27% | 5.05% | |
| 5. | BCRX | 10,660,349 | $86,029 | +16% | 5% |
| Company | Symbol | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2019-02-14 | ||||
| 2019-02-14 | ||||
| 2019-02-14 | ||||
| 2019-02-14 |
We use tracking technologies to enhance your user experience and to provide you service. By using Insider Monkey, you are giving us consent. Learn More
